Nicotinic stimulation induces Tristetraprolin over-production and attenuates inflammation in muscle

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1823, Issue 2, 2012, Pages 368-378

  Geyer, Brian C ^a   Ben Ari, Shani ^b   Barbash, Shahar ^b   Kilbourne, Jacqueline ^a   Mor, Tsafrir S ^a   Soreq, Hermona ^b  

^a ARIZONA STATE UNIVERSITY   (United States)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Acetylcholinesterase; Chemokine; Inflammation; MRNA processing; Muscle; Tristetraprolin

Indexed keywords

ACETYLCHOLINESTERASE; CXCL1 CHEMOKINE; I KAPPA B; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NICOTINE; PARAOXON; PROTEIN MCL 1; RNA BINDING PROTEIN; SERINE ARGININE RICH PROTEIN; TRANSCRIPTION FACTOR AP 1; TRISTETRAPROLIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CELL VIABILITY; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IN VIVO STUDY; MALE; MOUSE; MUSCLE EXCITATION; MUSCLE FUNCTION; MYOSITIS; MYOTUBE; NONHUMAN; POLYADENYLATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; QUADRICEPS FEMORIS MUSCLE; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL LINE; CHOLINESTERASE INHIBITORS; CYTOKINES; GENE EXPRESSION PROFILING; INFLAMMATION; MALE; MICE; MICROARRAY ANALYSIS; MUSCLE, SKELETAL; NICOTINE; NICOTINIC AGONISTS; PARAOXON; PROTO-ONCOGENE PROTEINS C-BCL-2; TRISTETRAPROLIN;

BACTERIA (MICROORGANISMS); MURINAE;

EID: 84855805125     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2011.11.001     Document Type: Article

References (91)

1. Duan H., Chai J., Sheng Z., Yao Y., Yin H., Liang L., Shen C., Lin J. Effect of burn injury on apoptosis and expression of apoptosis-related genes/proteins in skeletal muscles of rats. Apoptosis 2009, 14:52-65.
2. De Bleecker J.L., De Paepe B., Vanwalleghem I.E., Schroder J.M. Differential expression of chemokines in inflammatory myopathies. Neurology 2002, 58:1779-1785.
3. Rich M.M. The control of neuromuscular transmission in health and disease. Neuroscientist 2006, 12:134-142.
4. Soreq H., Seidman S. Acetylcholinesterase - new roles for an old actor. Nat. Rev. Neurosci. 2001, 2:294-302.
5. Gallowitsch-Puerta M., Pavlov V.A. Neuro-immune interactions via the cholinergic anti-inflammatory pathway. Life Sci. 2007, 80:2325-2329.
6. Shaked I., Meerson A., Wolf Y., Avni R., Greenberg D., Gilboa-Geffen A., Soreq H. MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase. Immunity 2009, 31:965-973.
7. Song P., Sekhon H.S., Lu A., Arredondo J., Sauer D., Gravett C., Mark G.P., Grando S.A., Spindel E.R. M3 muscarinic receptor antagonists inhibit small cell lung carcinoma growth and mitogen-activated protein kinase phosphorylation induced by acetylcholine secretion. Cancer Res. 2007, 67:3936-3944.
8. Liu J.J., Li D.L., Zhou J., Sun L., Zhao M., Kong S.S., Wang Y.H., Yu X.J., Zhou J., Zang W.J. Acetylcholine prevents angiotensin II-induced oxidative stress and apoptosis in H9c2 cells. Apoptosis 2010, 16:94-103.
9. Marino M., Scuderi F., Provenzano C., Bartoccioni E. Skeletal muscle cells: from local inflammatory response to active immunity. Gene Ther. 2010, 18:109-116.
10. Englund P., Lindroos E., Nennesmo I., Klareskog L., Lundberg I.E. Skeletal muscle fibers express major histocompatibility complex class II antigens independently of inflammatory infiltrates in inflammatory myopathies. Am. J. Pathol. 2001, 159:1263-1273.
11. Wiendl H., Hohlfeld R., Kieseier B.C. Immunobiology of muscle: advances in understanding an immunological microenvironment. Trends Immunol. 2005, 26:373-380.
12. Pedersen B.K., Febbraio M.A. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol. Rev. 2008, 88:1379-1406.
13. Acharyya S., Villalta S.A., Bakkar N., Bupha-Intr T., Janssen P.M., Carathers M., Li Z.W., Beg A.A., Ghosh S., Sahenk Z., Weinstein M., Gardner K.L., Rafael-Fortney J.A., Karin M., Tidball J.G., Baldwin A.S., Guttridge D.C. Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J. Clin. Invest. 2007, 117:889-901.
14. Tracey K.J. Reflex control of immunity. Nat. Rev. Immunol. 2009, 9:418-428.
15. Leite P.E., Lagrota-Candido J., Moraes L., D'Elia L., Pinheiro D.F., da Silva R.F., Yamasaki E.N., Quirico-Santos T. Nicotinic acetylcholine receptor activation reduces skeletal muscle inflammation of mdx mice. J. Neuroimmunol. 2010, 227:44-51.
16. Asomugha C.O., Linn D.M., Linn C.L. ACh receptors link two signaling pathways to neuroprotection against glutamate-induced excitotoxicity in isolated RGCs. J. Neurochem. 2010, 112:214-226.
17. da Penha Berzaghi M., Cooper J., Castren E., Zafra F., Sofroniew M., Thoenen H., Lindholm D. Cholinergic regulation of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) but not neurotrophin-3 (NT-3) mRNA levels in the developing rat hippocampus. J. Neurosci. 1993, 13:3818-3826.
18. Sandri M., El Meslemani A.H., Sandri C., Schjerling P., Vissing K., Andersen J.L., Rossini K., Carraro U., Angelini C. Caspase 3 expression correlates with skeletal muscle apoptosis in Duchenne and facioscapulo human muscular dystrophy. A potential target for pharmacological treatment?. J. Neuropathol. Exp. Neurol. 2001, 60:302-312.
19. Siu P.M., Tam E.W., Teng B.T., Pei X.M., Ng J.W., Benzie I.F., Mak A.F. Muscle apoptosis is induced in pressure-induced deep tissue injury. J. Appl. Physiol. 2009, 107:1266-1275.
20. Warren G.L., Summan M., Gao X., Chapman R., Hulderman T., Simeonova P.P. Mechanisms of skeletal muscle injury and repair revealed by gene expression studies in mouse models. J. Physiol. 2007, 582:825-841.
21. Moore M.J., Wang Q., Kennedy C.J., Silver P.A. An alternative splicing network links cell-cycle control to apoptosis. Cell 2010, 142:625-636.
22. Leeman J.R., Gilmore T.D. Alternative splicing in the NF-kappaB signaling pathway. Gene 2008, 423:97-107.
23. Daoud R., Da Penha Berzaghi M., Siedler F., Hubener M., Stamm S. Activity-dependent regulation of alternative splicing patterns in the rat brain. Eur. J. Neurosci. 1999, 11:788-802.
24. Zimmerman G., Njunting M., Ivens S., Tolner E.A., Behrens C.J., Gross M., Soreq H., Heinemann U., Friedman A. Acetylcholine-induced seizure-like activity and modified cholinergic gene expression in chronically epileptic rats. Eur. J. Neurosci. 2008, 27:965-975.
25. Roe D.F., Craviso G.L., Waymire J.C. Nicotinic stimulation modulates tyrosine hydroxylase mRNA half-life and protein binding to the 3'UTR in a manner that requires transcription. Brain Res. Mol. Brain Res. 2004, 120:91-102.
26. Clement S.L., Scheckel C., Stoecklin G., Lykke-Andersen J. Phosphorylation of tristetraprolin by MK2 impairs AU-rich element mRNA decay by preventing deadenylase recruitment. Mol. Cell. Biol. 2011, 31:256-266.
27. Lykke-Andersen J., Wagner E. Recruitment and activation of mRNA decay enzymes by two ARE-mediated decay activation domains in the proteins TTP and BRF-1. Genes Dev. 2005, 19:351-361.
28. Jing Q., Huang S., Guth S., Zarubin T., Motoyama A., Chen J., Di Padova F., Lin S.C., Gram H., Han J. Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 2005, 120:623-634.
29. Carballo E., Blackshear P.J. Roles of tumor necrosis factor-alpha receptor subtypes in the pathogenesis of the tristetraprolin-deficiency syndrome. Blood 2001, 98:2389-2395.
30. Sauer I., Schaljo B., Vogl C., Gattermeier I., Kolbe T., Muller M., Blackshear P.J., Kovarik P. Interferons limit inflammatory responses by induction of tristetraprolin. Blood 2006, 107:4790-4797.
31. Ogilvie R.L., Abelson M., Hau H.H., Vlasova I., Blackshear P.J., Bohjanen P.R. Tristetraprolin down-regulates IL-2 gene expression through AU-rich element-mediated mRNA decay. J. Immunol. 2005, 174:953-961.
32. Al-Souhibani N., Al-Ahmadi W., Hesketh J.E., Blackshear P.J., Khabar K.S. The RNA-binding zinc-finger protein tristetraprolin regulates AU-rich mRNAs involved in breast cancer-related processes. Oncogene 2010, 29:4205-4215.
33. Lee H.H., Vo M.T., Kim H.J., Lee U.H., Kim C.W., Kim H.K., Ko M.S., Lee W.H., Cha S.J., Min Y.J., Choi D.H., Suh H.S., Lee B.J., Park J.W., Cho W.J. Stability of the LATS2 tumor suppressor gene is regulated by tristetraprolin. J. Biol. Chem. 2010, 285:17329-17337.
34. Kim C.W., Kim H.K., Vo M.T., Lee H.H., Kim H.J., Min Y.J., Cho W.J., Park J.W. Tristetraprolin controls the stability of cIAP2 mRNA through binding to the 3'UTR of cIAP2 mRNA. Biochem. Biophys. Res. Commun. 2010, 400:46-52.
35. Joe Y., Kim H.J., Kim S., Chung J., Ko M.S., Lee W.H., Chang K.C., Park J.W., Chung H.T. Tristetraprolin mediates the anti-inflammatory effects of nicotine in LPS-stimulated macrophages. J. Biol. Chem. 2011, 286:24735-24742.
36. Evron T., Geyer B.C., Cherni I., Muralidharan M., Kilbourne J., Fletcher S.P., Soreq H., Mor T.S. Plant-derived human acetylcholinesterase-R provides protection from lethal organophosphate poisoning and its chronic aftermath. FASEB J. 2007, 21:2961-2969.
37. Siow N.L., Choi R.C., Cheng A.W., Jiang J.X., Wan D.C., Zhu S.Q., Tsim K.W. A cyclic AMP-dependent pathway regulates the expression of acetylcholinesterase during myogenic differentiation of C2C12 cells. J. Biol. Chem. 2002, 277:36129-36136.
38. King E.M., Kaur M., Gong W., Rider C.F., Holden N.S., Newton R. Regulation of tristetraprolin expression by interleukin-1 beta and dexamethasone in human pulmonary epithelial cells: roles for nuclear factor-kappa B and p38 mitogen-activated protein kinase. J. Pharmacol. Exp. Ther. 2009, 330:575-585.
39. Mahtani K.R., Brook M., Dean J.L., Sully G., Saklatvala J., Clark A.R. Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mol. Cell. Biol. 2001, 21:6461-6469.
40. Zhang H., Hu J., Recce M., Tian B. PolyA_DB: a database for mammalian mRNA polyadenylation. Nucleic Acids Res. 2005, 33:D116-D120.
41. Le Texier V., Riethoven J.J., Kumanduri V., Gopalakrishnan C., Lopez F., Gautheret D., Thanaraj T.A. AltTrans: transcript pattern variants annotated for both alternative splicing and alternative polyadenylation. BMC Bioinformatics 2006, 7:169.
42. Ben-Ari S., Toiber D., Sas A.S., Soreq H., Ben-Shaul Y. Modulated splicing-associated gene expression in P19 cells expressing distinct acetylcholinesterase splice variants. J. Neurochem. 2006, 97(Suppl. 1):24-34.
43. Toiber D., Azkona G., Ben-Ari S., Toran N., Soreq H., Dierssen M. Engineering DYRK1A overdosage yields Down syndrome-characteristic cortical splicing aberrations. Neurobiol. Dis. 2010, 40:348-359.
44. Churchill G.A. Fundementals of experimental design for cDNA microarrays. Nat. Genet. 2002, 32:490-495.
45. Dombkowski A.A., Thibodeau B.J., Starcevic S.L., Novak R.F. Gene-specific dye bias in microarray reference designs. FEBS Lett. 2004, 560:120-124.
46. Ben-Shaul Y., Bergman H., Soreq H. Identifying subtle interrelated changes in functional gene categories using continuous measures of gene expression. Bioinformatics 2005, 21:1129-1137.
47. Ben-Shaul Y., BenMoyal-Segal S., Ben-Ari S., Bergman H., Soreq H. Adaptive acetylcholinesterase splicing patterns attenuate 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice. EJN 2006, 23:2915-2922.
48. Jelen N., Ule J., Zivin M. Cholinergic regulation of striatal Nova mRNAs. Neuroscience 2010, 169:619-627.
49. Liu J.J., Li D.L., Zhou J., Sun L., Zhao M., Kong S.S., Wang Y.H., Yu X.J., Zhou J., Zang W.J. Acetylcholine prevents angiotensin II-induced oxidative stress and apoptosis in H9c2 cells. Apoptosis 2011, 16:94-103.
50. Waldburger J.M., Boyle D.L., Pavlov V.A., Tracey K.J., Firestein G.S. Acetylcholine regulation of synoviocyte cytokine expression by the alpha7 nicotinic receptor. Arthritis Rheum. 2008, 58:3439-3449.
51. Sadis C., Teske G., Stokman G., Kubjak C., Claessen N., Moore F., Loi P., Diallo B., Barvais L., Goldman M., Florquin S., Le Moine A. Nicotine protects kidney from renal ischemia/reperfusion injury through the cholinergic anti-inflammatory pathway. PLoS One 2007, 2:e469.
52. Datta S., Biswas R., Novotny M., Pavicic P.G., Herjan T., Mandal P., Hamilton T.A. Tristetraprolin regulates CXCL1 (KC) mRNA stability. J. Immunol. 2008, 180:2545-2552.
53. Cisson C.M., Wilson B.W. Paraoxon increases the rate of synthesis of acetylcholinesterase in cultured muscle. Toxicol. Lett. 1981, 9:131-135.
54. Kaufer D., Friedman A., Seidman S., Soreq H. Anticholinesterases induce multigenic transcriptional feedback response suppressing cholinergic neurotransmission. Chem. Biol. Interact. 1999, 119-120:349-360.
55. Lleres D., Denegri M., Biggiogera M., Ajuh P., Lamond A.I. Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. EMBO Rep. 2010, 11:445-451.
56. Kleinridders A., Pogoda H.M., Irlenbusch S., Smyth N., Koncz C., Hammerschmidt M., Bruning J.C. PLRG1 is an essential regulator of cell proliferation and apoptosis during vertebrate development and tissue homeostasis. Mol. Cell. Biol. 2009, 29:3173-3185.
57. Le Gouill S., Podar K., Harousseau J.L., Anderson K.C. Mcl-1 regulation and its role in multiple myeloma. Cell Cycle 2004, 3:1259-1262.
58. Kojima S., Hyakutake A., Koshikawa N., Nakagawara A., Takenaga K. MCL-1V, a novel mouse antiapoptotic MCL-1 variant, generated by RNA splicing at a non-canonical splicing pair. Biochem. Biophys. Res. Commun. 2010, 391:492-497.
59. De Biasio A., Vrana J.A., Zhou P., Qian L., Bieszczad C.K., Braley K.E., Domina A.M., Weintraub S.J., Neveu J.M., Lane W.S., Craig R.W. N-terminal truncation of antiapoptotic MCL1, but not G2/M-induced phosphorylation, is associated with stabilization and abundant expression in tumor cells. J. Biol. Chem. 2007, 282:23919-23936.
60. Brewer B.Y., Ballin J.D., Fialcowitz-White E.J., Blackshear P.J., Wilson G.M. Substrate dependence of conformational changes in the RNA-binding domain of tristetraprolin assessed by fluorescence spectroscopy of tryptophan mutants. Biochemistry 2006, 45:13807-13817.
61. Emmons J., Townley-Tilson W.H., Deleault K.M., Skinner S.J., Gross R.H., Whitfield M.L., Brooks S.A. Identification of TTP mRNA targets in human dendritic cells reveals TTP as a critical regulator of dendritic cell maturation. RNA 2008, 14:888-902.
62. Stoecklin G., Tenenbaum S.A., Mayo T., Chittur S.V., George A.D., Baroni T.E., Blackshear P.J., Anderson P. Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin. J. Biol. Chem. 2008, 283:11689-11699.
63. Tsuneki H., Salas R., Dani J.A. Mouse muscle denervation increases expression of an alpha7 nicotinic receptor with unusual pharmacology. J. Physiol. 2003, 547:169-179.
64. Lindstrom J.M. Acetylcholine receptors and myasthenia. Muscle Nerve 2000, 23:453-477.
65. Ward J.M., Martyn J.A. Burn injury-induced nicotinic acetylcholine receptor changes on muscle membrane. Muscle Nerve 1993, 16:348-354.
66. Reyes-Reyna S., Stegall T., Krolick K.A. Muscle responds to an antibody reactive with the acetylcholine receptor by up-regulating monocyte chemoattractant protein 1: a chemokine with the potential to influence the severity and course of experimental myasthenia gravis. J. Immunol. 2002, 169:1579-1586.
67. Shandley S., Martinez S., Krolick K. IL-4 receptor as a bridge between the immune system and muscle in experimental myasthenia gravis I: up-regulation of muscle IL-15 by IL-4. Clin. Immunol. 2009, 132:246-256.
68. De Paepe B., Creus K.K., De Bleecker J.L. Chemokine profile of different inflammatory myopathies reflects humoral versus cytotoxic immune responses. Ann. N. Y. Acad. Sci. 2007, 1109:441-453.
69. Sell H., Dietze-Schroeder D., Kaiser U., Eckel J. Monocyte chemotactic protein-1 is a potential player in the negative cross-talk between adipose tissue and skeletal muscle. Endocrinology 2006, 147:2458-2467.
70. Sell H., Eckel J. Monocyte chemotactic protein-1 and its role in insulin resistance. Curr. Opin. Lipidol. 2007, 18:258-262.
71. Valle A., O'Connor D.T., Taylor P., Zhu G., Montgomery G.W., Slagboom P.E., Martin N.G., Whitfield J.B. Butyrylcholinesterase: association with the metabolic syndrome and identification of 2 gene loci affecting activity. Clin. Chem. 2006, 52:1014-1020.
72. Ben-Ari S., Ofek K., Barbash S., Meiri H., Kovalev E., Greenberg D.S., Soreq H., Shoham S. Similar cation channels mediate protection from cerebellar exitotoxicity by exercise and inheritance. J. Cell. Mol. Med. 2011, 10.1111/j.1582-4934.2011.01331.x.
73. Ravikumar R., Flora G., Geddes J.W., Hennig B., Toborek M. Nicotine attenuates oxidative stress, activation of redox-regulated transcription factors and induction of proinflammatory genes in compressive spinal cord trauma. Brain Res. Mol. Brain Res. 2004, 124:188-198.
74. Liang J., Lei T., Song Y., Yanes N., Qi Y., Fu M. RNA-destabilizing factor tristetraprolin negatively regulates NF-kappaB signaling. J. Biol. Chem. 2009, 284:29383-29390.
75. Schichl Y.M., Resch U., Hofer-Warbinek R., de Martin R. Tristetraprolin impairs NF-kappaB/p65 nuclear translocation. J. Biol. Chem. 2009, 284:29571-29581.
76. Lai W.S., Thompson M.J., Blackshear P.J. Characteristics of the intron involvement in the mitogen-induced expression of Zfp-36. J. Biol. Chem. 1998, 273:506-517.
77. Brook M., Tchen C.R., Santalucia T., McIlrath J., Arthur J.S., Saklatvala J., Clark A.R. Posttranslational regulation of tristetraprolin subcellular localization and protein stability by p38 mitogen-activated protein kinase and extracellular signal-regulated kinase pathways. Mol. Cell. Biol. 2006, 26:2408-2418.
78. Marchese F.P., Aubareda A., Tudor C., Saklatvala J., Clark A.R., Dean J.L. MAPKAP kinase 2 blocks tristetraprolin-directed mRNA decay by inhibiting CAF1 deadenylase recruitment. J. Biol. Chem. 2010, 285:27590-27600.
79. Undeger U., Basaran N. Effects of pesticides on human peripheral lymphocytes in vitro: induction of DNA damage. Arch. Toxicol. 2005, 79:169-176.
80. Pegan K., Matkovic U., Mars T., Mis K., Pirkmajer S., Brecelj J., Grubic Z. Acetylcholinesterase is involved in apoptosis in the precursors of human muscle regeneration. Chem. Biol. Interact. 2010, 187:96-100.
81. Grisaru D., Deutsch V., Shapira M., Pick M., Sternfeld M., Melamed-Book N., Kaufer D., Galyam N., Gait M.J., Owen D., Lessing J.B., Eldor A., Soreq H. ARP, a peptide derived from the stress-associated acetylcholinesterase variant, has hematopoietic growth promoting activities. Mol. Med. 2001, 7:93-105.
82. Saleh A.M., Vijayasarathy C., Masoud L., Kumar L., Shahin A., Kambal A. Paraoxon induces apoptosis in EL4 cells via activation of mitochondrial pathways. Toxicol. Appl. Pharmacol. 2003, 190:47-57.
83. Yang B., Lin H., Xu C., Liu Y., Wang H., Han H., Wang Z. Choline produces cytoprotective effects against ischemic myocardial injuries: evidence for the role of cardiac m3 subtype muscarinic acetylcholine receptors. Cell. Physiol. Biochem. 2005, 16:163-174.
84. Moulian N., Bidault J., Truffault F., Yamamoto A.M., Levasseur P., Berrih-Aknin S. Thymocyte Fas expression is dysregulated in myasthenia gravis patients with anti-acetylcholine receptor antibody. Blood 1997, 89:3287-3295.
85. Willis S.N., Chen L., Dewson G., Wei A., Naik E., Fletcher J.I., Adams J.M., Huang D.C. Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev. 2005, 19:1294-1305.
86. Rahmani M., Davis E.M., Bauer C., Dent P., Grant S. Apoptosis induced by the kinase inhibitor BAY 43-9006 in human leukemia cells involves down-regulation of Mcl-1 through inhibition of translation. J. Biol. Chem. 2005, 280:35217-35227.
87. Sandberg R., Neilson J.R., Sarma A., Sharp P.A., Burge C.B. Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites. Science 2008, 320:1643-1647.
88. Goswami S., Tarapore R.S., Teslaa J.J., Grinblat Y., Setaluri V., Spiegelman V.S. MicroRNA-340-mediated degradation of microphthalmia-associated transcription factor mRNA is inhibited by the coding region determinant-binding protein. J. Biol. Chem. 2010, 285:20532-20540.
89. Warr M.R., Shore G.C. Unique biology of Mcl-1: therapeutic opportunities in cancer. Curr. Mol. Med. 2008, 8:138-147.
90. Akgul C., Turner P.C., White M.R., Edwards S.W. Functional analysis of the human MCL-1 gene. Cell. Mol. Life Sci. 2000, 57:684-691.
91. Carballo E., Lai W.S., Blackshear P.J. Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability. Blood 2000, 95:1891-1899.